RxDoctor Payments Data

Natalie Marshall

Medical · San Antonio, TXNPI 1548739451

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 95.4% of the total across 422 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 12.0% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,229, 2.2 times the $996 reported in 2021. Among medical clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,855in general payments, 2019–2025

Across 422 payments — averaging $18.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Incyte Corporation$944
  • AbbVie$766
  • Johnson & Johnson$659
  • Sanofi$587
  • Amgen$514
  • Galderma Laboratories, L.p.$495
  • plus $4K from 21 others

What the payments were for

  • Food & beverage$7,49595%
  • Education$3595%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$7,855 in reported general payments places this provider in the 90th percentile of 1,490 medical providers in Texas.

See all medical providers in Texas →

Medicare billing

Part B allowed, 2024
$153,894
Medicare patients
507
Services billed
2,787

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Humira(Cf) PenAdalimumab18$122,539
Clobetasol Propionate75$1,862
Tacrolimus21$1,784
Metronidazole24$1,378
Fluorouracil17$1,266
Ketoconazole51$965
Doxycycline Hyclate23$460
Doxycycline Monohydrate15$448
Triamcinolone Acetonide36$412
Hydrocortisone27$298
ValacyclovirValacyclovir Hcl19$232
Mupirocin23$167
Clotrimazole14$145
Spironolactone16$127
Finasteride17$106

Paid to pharmacies, not to this prescriber.

Other medical in San Antonio

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →